← Back to Episodes
PODCAST

Not Knowing If It Counts: The Perimenopause Uncertainty Study

July 24, 2026·10:33·Episode 87

Quick Summary

A new NAMS study officially names perimenopause uncertainty as a clinically distinct and widespread experience — and explains why so many women feel dismissed or confused before they ever get a diagnosis. This episode also covers a promising randomized trial on compassionate mind training for menopause-related mood and anxiety, and takes a hard look at what "shows promise" actually means when a supplement brand uses it in a headline.

Not Knowing If It Counts: The Perimenopause Uncertainty Study

0:000:00

Key Takeaways

  • Perimenopause uncertainty — not knowing whether your symptoms are perimenopause or something else — is now recognized in peer-reviewed research as a clinically meaningful phenomenon, distinct from illness-related uncertainty.
  • The uncertainty isn't just uncomfortable; it delays validation, delays care, and has real mental health consequences for women in the transition.
  • Compassionate Mind Training (CMT), a structured group intervention rooted in self-compassion and emotion regulation, showed feasibility and early signal for reducing anxiety and low mood in a randomized controlled trial — though a fully powered effectiveness trial still needs to happen.
  • Elysium's NR-based supplement generated a headline claiming it "shows promise" for menopause symptoms — but the source is NutraIngredients, a trade publication, not a peer-reviewed journal, and no independent trial data was available at time of publishing.
  • For mood and anxiety specifically, non-hormonal, evidence-adjacent options like CMT are worth watching — particularly for women who can't or don't want to use HRT.

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.